dc.contributor.author |
Custodio, Nilton |
|
dc.contributor.author |
Montesinos, Rosa |
|
dc.contributor.author |
Lira, David |
|
dc.contributor.author |
Herrera-Perez, Eder |
|
dc.contributor.author |
Chavez, Kristy |
|
dc.contributor.author |
Hernandez-Cordova, Gustavo |
|
dc.contributor.author |
Cuenca, Jose |
|
dc.contributor.author |
Gamboa, Carlos |
|
dc.contributor.author |
Metcalf, Tatiana |
|
dc.date.accessioned |
2019-12-06T20:57:47Z |
|
dc.date.available |
2019-12-06T20:57:47Z |
|
dc.date.issued |
2019 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/7407 |
|
dc.description.abstract |
OBJECTIVES: To assess the psychometric properties of the Peruvian version of the Rowland Universal Dementia Assessment Scale (RUDAS-PE) to discriminate controls from patients with mild cognitive impairment (MCI) and early dementia (ED) in a population with a mid-level education. METHODS: A total of 133 patients from a memory clinic were administered the RUDAS-PE, INECO Frontal Screening, Addenbrooke's Cognitive Examination, and Mini-Mental State Examination. Results were compared against a neuropsychological evaluation (gold standard). Validity measures, internal consistency, and concurrent validity were calculated. RESULTS: Cronbach's alpha was 0.68; Pearson's ratio was 0.79 (P < .01). The area under the receiver-operating characteristics curve of the RUDAS to discriminate between ED and MCI was 89.0% (optimal cutoff at <21), whereas between MCI and controls, it was 99.0% (optimal cutoff at <24). CONCLUSIONS: The RUDAS-PE has acceptable psychometric properties performing well in its ability to discriminate controls from patients with MCI and ED. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
SAGE Publications |
|
dc.relation.ispartofseries |
American Journal of Alzheimer's Disease and Other Dementias |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.subject |
Addenbrooke Cognitive Examination |
en_US |
dc.subject |
aged |
en_US |
dc.subject |
Alzheimer disease |
en_US |
dc.subject |
Alzheimer's disease |
en_US |
dc.subject |
Alzheimer’s disease |
en_US |
dc.subject |
aminotransferase |
en_US |
dc.subject |
Article |
en_US |
dc.subject |
Beck Depression Inventory |
en_US |
dc.subject |
brief cognitive tests |
en_US |
dc.subject |
Clinical Dementia Rating |
en_US |
dc.subject |
cognitive impairment |
en_US |
dc.subject |
computer assisted tomography |
en_US |
dc.subject |
controlled study |
en_US |
dc.subject |
creatinine |
en_US |
dc.subject |
cyanocobalamin |
en_US |
dc.subject |
dementia |
en_US |
dc.subject |
dementia assessment |
en_US |
dc.subject |
diagnostic accuracy |
en_US |
dc.subject |
diagnostic test accuracy study |
en_US |
dc.subject |
disorders of higher cerebral function |
en_US |
dc.subject |
DSM-5 |
en_US |
dc.subject |
education |
en_US |
dc.subject |
enzyme linked immunosorbent assay |
en_US |
dc.subject |
female |
en_US |
dc.subject |
folic acid |
en_US |
dc.subject |
free liothyronine index |
en_US |
dc.subject |
free thyroxine index |
en_US |
dc.subject |
glucose |
en_US |
dc.subject |
gold standard |
en_US |
dc.subject |
human |
en_US |
dc.subject |
INECO Frontal Screening |
en_US |
dc.subject |
Likert scale |
en_US |
dc.subject |
major clinical study |
en_US |
dc.subject |
male |
en_US |
dc.subject |
mild cognitive impairment |
en_US |
dc.subject |
neurocognitive disorders |
en_US |
dc.subject |
neuropsychological test |
en_US |
dc.subject |
neuropsychological tests |
en_US |
dc.subject |
nuclear magnetic resonance imaging |
en_US |
dc.subject |
outcome assessment |
en_US |
dc.subject |
Peru |
en_US |
dc.subject |
pilot study |
en_US |
dc.subject |
predictive value |
en_US |
dc.subject |
psychometry |
en_US |
dc.subject |
questionnaire |
en_US |
dc.subject |
receiver operating characteristic |
en_US |
dc.subject |
Rey auditory verbal learning test |
en_US |
dc.subject |
Rowland Universal Dementia Assessment Scale |
en_US |
dc.subject |
scoring system |
en_US |
dc.subject |
sensitivity and specificity |
en_US |
dc.subject |
thyrotropin |
en_US |
dc.subject |
trail making test |
en_US |
dc.subject |
urea |
en_US |
dc.subject |
validation process |
en_US |
dc.subject |
Wechsler adult intelligence scale |
en_US |
dc.subject |
Wechsler memory scale |
en_US |
dc.subject |
Wisconsin Card Sorting Test |
en_US |
dc.title |
Validation of the RUDAS in Patients With a Middle-Level Education in Lima, Peru. |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1177/1533317519869709 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.04 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.24 |
|
dc.relation.issn |
1938-2731 |
|